Cooke et al. [335] designed a shear-thinning controlled release vehicle consisting of MC and HA to deliver epidermal growth factor (EGF) and PEG-EGF for the treatment of stroke (via surgery) [335]. This evidence concerns the gene EGF and stroke disorder.